Guardant Shield Colorectal Cancer Screening | MicrobiomeTrials← Back to trialsNCT07436637
Guardant Shield Colorectal Cancer Screening
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-07-22Est. Completion: 2027-04-01
Enrollment target: 500 participants Locations- University of Miami, Miami, Florida, United States
Other microbiome trials you might be interested in
CRC (Colorectal Cancer)
Efficacy and safety of retlirafusp alfa combined with bevacizumab and chemotherapy with or without short-course radiothe…
Wuhan, ChinaEst. completion Jun 30, 2029
Endometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Dedifferentiated CarcinomaEndometrial Endometrioid AdenocarcinomaEndometrial Mixed Cell AdenocarcinomaEndometrial Mucinous Adenocarcinoma
Endometrial Undifferentiated Carcinoma
Endometrioid Adenocarcinoma
Recurrent Endometrial Carcinoma
This phase II trial tests whether the combination of nivolumab and ipilimumab is better than nivolumab alone to shrink t…
Birmingham, United StatesEst. completion Jul 30, 2032
Advanced/Metastatic Solid Tumors
This is a multicenter, open-label, multiple-dose, FIH Phase 1a/1b study. Phase 1a adopts an accelerated titration design…
Los Angeles, United StatesEst. completion Jun 2028